Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sodium Propionate Combined With Anti-PD-1 Immunotherapy on Tumor Efficacy in Gastric Cancer Patients

NCT07615907 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT07615907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07615907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sodium Propionate Combined With Anti-PD-1 Immunotherapy on Tumor Efficacy in Gastric Cancer Patients
Lead sponsor
Jinling Hospital, China
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 30, 2026
Completion date
August 30, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer (gc)